Search

everythinglearnresearchcommunity

for

Search:↓

Oral and topical tranexamic acid effectively and safely improve melasma.

MIS-A is a severe complication after COVID-19, mostly in young black males, needing more research and awareness.

A new mutation in the mitochondrial DNA was found in a boy with MELAS, even though his family didn't show typical signs.

Msx2 deficiency in mice leads to bone growth and organ development problems.

A woman with a rare type of dermatomyositis improved with low-dose prednisone and methotrexate.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

MRL/MpJ mice heal burns slower with more scarring and less tissue regeneration than BALB/c mice.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

A patient with a PLEC mutation has epidermolysis bullosa, muscular dystrophy, and myasthenia gravis, which improved with steroid treatment.

Most children with MIS-C showed significant improvement by 6 months.

Removing MCPIP1 from myeloid cells in mice leads to hair loss and prevents skin tumors but causes pigmented spots.

The woman's facial symptoms are best explained by primary Sjögren’s Syndrome.

Mesenchymal stem cell therapy shows promise for treating certain inflammatory skin diseases, but more research is needed.

SLE and DM can coexist but are rare and need careful evaluation.

Multiomics is revolutionizing biology by enabling breakthroughs in research and disease diagnosis.

Certain proteins involved in DNA modification may affect the genetic changes in systemic lupus erythematosus and could indicate the disease's activity.

Early diagnosis and treatment of myositis in SLE patients lead to positive outcomes.

Vitamin D affects Msx1 protein expression and may influence mineralized tissue health.

LC-MS/MS is more reliable than immunoassays for diagnosing 21-hydroxylase deficiency.

Increasing isoleucine intake improved skin and health issues in an infant with maple syrup urine disease.

Mitochondriopathy may cause eyelash loss.

New treatments for relapsing multiple sclerosis are more effective and convenient but have higher risks of serious side effects.

The case shows how hard it is to tell apart Multiple Autoimmune Syndrome from other similar autoimmune conditions, but correct diagnosis is key for treatment to work.

Early diagnosis and treatment of myositis in SLE patients lead to better outcomes.

Polysulfonic acid mucopolysaccharide can reduce skin scarring.

MicroRNAs could help assess and manage multiple chronic diseases.

The article concludes that proper injection techniques and patient education can prevent serious skin reactions from multiple sclerosis medications.